Vulvodynia Creams

Vulvodynia and pelvic pain vaginal creams are compounded, prescription topical preparations. Each one combines one or more medications — commonly gabapentin, amitriptyline, baclofen, lidocaine, or ketotifen — in a cream base intended for vulvar and vaginal tissue, at the strengths your prescriber chooses.

Vulvodynia is chronic vulvar pain lasting at least three months without a clear identifiable cause, which may have potential associated factors (2015 ISSVD, ISSWSH and IPPS consensus terminology). It is described by where it is felt (localized, such as vestibulodynia at the vaginal opening, or generalized), whether it is provoked by touch or happens spontaneously, and whether it began with first contact or after a period of pain-free contact. Many people have provoked vestibulodynia — localized pain at the vestibule that appears with touch, tampon use, or intercourse.

How does it work?

Each active works on a different part of the pain picture, which is why prescribers often combine them.

Gabapentin modulates calcium channels on sensory nerves, reducing the neuropathic pain signalling that can make vulvar tissue painfully sensitive. Amitriptyline is a tricyclic antidepressant that, at pain-management doses, dampens pain transmission in the nervous system. Baclofen is a GABA-B agonist that reduces muscle tension, which matters because pelvic floor muscle overactivity is common alongside vulvar pain. Lidocaine is a local anesthetic that numbs the surface tissue it touches. Ketotifen is a mast-cell stabilizer, included because mast cell activity has been implicated in some vestibulodynia (Frontiers in Cellular and Infection Microbiology, 2023).

Applying these to the vulva puts the medication where the pain is, at doses far lower than the oral equivalents. That is the rationale — not proof that it works better than other approaches.

What is it used for?

These creams are prescribed for chronic vulvar pain, most often provoked vestibulodynia, and sometimes for vulvar pain that accompanies pelvic floor dysfunction. Vulvodynia is a diagnosis of exclusion: ACOG describes an evaluation that includes a careful history, a cotton-swab test to map where the pain is, testing for infection, and a musculoskeletal assessment, with specific treatable conditions ruled out first (ACOG Committee Opinion 673). That workup matters, because a cream will not help pain that is actually coming from a dermatologic condition, an infection, or hormonal changes.

Every use of these combinations is off-label. Only a licensed provider can decide whether one is appropriate for you and which actives and strengths to use. Bayview Pharmacy does not provide consultations and does not determine appropriateness, and a valid prescription is required.

What does the evidence show?

Honestly: the evidence for compounded topical treatments in vulvodynia is thin, and it is worth knowing that before you start.

The clearest finding is a negative one. A randomized trial of topical lidocaine 5% for provoked vestibulodynia did not outperform placebo — it performed slightly worse (20% response versus 33% for placebo) (ACOG Committee Opinion 673). ACOG also states plainly that few randomized trials of vulvodynia treatment exist at all, and that most of the evidence base is clinical experience and observational work. A 2024 scoping review of interventions for localized provoked vulvodynia concluded there is “insufficient evidence to suggest the superiority of one treatment modality for LPV relative to others,” while noting that pelvic floor physical therapy showed superior outcomes to topical lidocaine in head-to-head trials, and that cognitive behavioral therapy produced benefits comparable to or exceeding pharmacologic interventions (Rains et al., International Journal of Women's Health, 2024).

Topical gabapentin, amitriptyline, and baclofen have not been tested against placebo in vulvodynia with anything like the same rigor; they are used on the strength of clinical experience and their oral track record in neuropathic pain. Ketotifen's rationale is newer still: mast cell accumulation has been documented in vulvar tissue, and ketotifen reduced vulvar sensitivity in a rat model, but that work is preclinical and has not been confirmed in human clinical trials (Frontiers in Cellular and Infection Microbiology, 2023).

The National Vulvodynia Association puts the practical consequence well: there is no single treatment that helps everyone, and finding the right combination is a trial-and-error process (NVA, Vulvodynia Treatments). A cream may be a reasonable thing to try as part of a plan that also includes physical therapy, psychological support, and treatment of any underlying cause. It is not a substitute for that plan.

How do the formulas compare?

Bayview compounds these combinations to prescriber order. The table describes what each active contributes; it is not a statement that one formula works better than another for any particular person.

Formulas are described for education only and are not a statement that any combination is better for a particular person. Your prescriber selects the actives, strengths, base, and directions. All of these combinations are off-label and are not FDA-approved.

How is it used?

Use it exactly as your prescriber directs. In practice, a small amount — often about a pea-sized amount, or one actuation of a 0.5 mL metered pump — is applied to the vestibule or the vulva, commonly once or twice daily, and some prescribers also direct an application before intercourse. Some direct a cotton-swab application to the vestibule specifically, so the cream reaches the small painful area rather than the whole vulva.

Wash your hands before and after applying. Many people are started on a lower strength and moved up if it is tolerated, and it is common to be asked to give a formula several weeks before judging it. Do not apply more than prescribed, do not use it internally unless your prescriber has told you to, and do not change the amount or frequency on your own. If you are also doing pelvic floor physical therapy or other treatment, keep going with it — the cream is meant to work alongside that, not replace it. A Bayview pharmacist is available if you have questions about your prescription.

Side effects & safety

The most common problem is local: burning, stinging, or irritation when the cream is applied, especially in the first days. Vulvar tissue that is already painful is often sensitive to anything applied to it. Tell your prescriber if burning is severe or does not settle — sometimes the base, the strength, or a specific active is the problem.

Lidocaine-containing creams numb the tissue, which can reduce your ability to feel injury during intercourse, and they carry the same toxicity cautions as other lidocaine products: do not exceed the amount you were prescribed, do not apply to large areas or broken skin, and seek care for ringing in the ears, numbness around the mouth, dizziness, confusion, or an irregular heartbeat.

A practical note on contraception: some of these creams are made in oil-based (anhydrous) bases, and oil-based products can weaken latex condoms and diaphragms. If you rely on latex barrier contraception, ask your prescriber or pharmacist about your specific base. Numbing agents can also transfer to a partner. Tell your prescriber about pregnancy, plans for pregnancy, or breastfeeding — these creams should be avoided in pregnancy and lactation unless you have specifically discussed it with your prescriber.

Who should not use it?

These creams are not appropriate for everyone. Do not use one if you are allergic to any active in it or to any component of the base. They are generally avoided in pregnancy and breastfeeding unless your prescriber has specifically weighed it with you. Extra caution is needed if you already take an oral form of one of the same medications, since the topical dose adds to it; if you have significant heart, liver, or kidney disease; if you have a seizure disorder; or if you take other sedating medications, since drowsiness can add up.

Amitriptyline belongs to a class of antidepressants that carries a warning about increased suicidal thoughts and behavior in children, teenagers, and young adults; if a cream containing amitriptyline is prescribed for a young person, that risk should be discussed with the prescriber. Tell your prescriber your full health history, allergies, and every medication and supplement you take, so they can decide whether one of these combinations is appropriate for you.

How should it be stored?

Store at room temperature, away from heat, direct light, and moisture, unless your label says otherwise. Keep the tube or pump tightly closed and out of the reach of children and pets — these creams contain real doses of medication and are not safe if swallowed. Do not freeze. Do not use the cream after its beyond-use date, and do not use it if the color, smell, or texture has changed or the product has separated. Do not share it with anyone, even someone with similar symptoms, and dispose of unused medication as your pharmacist directs.

Why is this compounded?

There is no commercially manufactured, FDA-approved cream that contains these actives at these strengths for vulvar use. Gabapentin, amitriptyline, baclofen, and ketotifen are approved as oral or ophthalmic products, not as vulvar or vaginal creams, so a prescriber who wants to deliver them to the vestibule has to have them compounded. Compounding also lets a prescriber combine two or three actives in one application, adjust a strength up or down based on how you tolerate it, choose a base suited to vulvar and vaginal tissue, and leave out a preservative or excipient you react to.

As a 503A compounding pharmacy, Bayview Pharmacy prepares each order in small batches under USP <795> standards using quality ingredients, in a tube or a metered pump as ordered. Compounded preparations are not FDA-approved, they have not been evaluated by the FDA for safety or effectiveness in this use, and a valid prescription is required.